This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest

Exploring Nasal Casts in Nasal Drug Development
Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Navigating the Shift to more sustainable Low GWP propellants in pMDIs
Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

In Silico Modelling for Orally Inhaled Drug Development (OINDP)
Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Sustainable Propellants and Bioequivalence Innovation in OINDPs
Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions